diquafosol has been researched along with Graft vs Host Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukui, M; Kamoi, M; Kozuki, N; Mori, T; Mukai, S; Ogawa, Y; Okamoto, S; Saijo-Ban, Y; Tsubota, K; Uchino, M; Yamane, M | 1 |
| Fukui, M; Kamoi, M; Kawakita, T; Mukai, S; Ogawa, Y; Saijo-Ban, Y; Simmura, S; Tsubota, K; Yaguchi, S; Yamane, M | 1 |
2 other study(ies) available for diquafosol and Graft vs Host Disease
| Article | Year |
|---|---|
Long-Term Topical Diquafosol Tetrasodium Treatment of Dry Eye Disease Caused by Chronic Graft-Versus-Host Disease: A Retrospective Study.
Topics: Adult; Aged; Conjunctiva; Cornea; Dry Eye Syndromes; Female; Graft vs Host Disease; Humans; Male; Middle Aged; Mucins; Ophthalmic Solutions; Polyphosphates; Retrospective Studies; Tears; Uracil Nucleotides | 2018 |
Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.
Topics: Administration, Topical; Aged; Alanine; Drug Therapy, Combination; Dry Eye Syndromes; Enzyme Inhibitors; Female; Fluorescein; Fluorescent Dyes; Follow-Up Studies; Graft vs Host Disease; Humans; Middle Aged; Ophthalmic Solutions; Pemphigoid, Benign Mucous Membrane; Polyphosphates; Purinergic P2Y Receptor Agonists; Quinolones; Treatment Outcome; Uracil Nucleotides; Visual Acuity | 2015 |